Independent provider comparison
Updated September 21, 2026
Hers vs MEDVi: Which GLP-1 provider is better?
A side-by-side look at total cost, medication format, care, commitment and the situations where each option makes more sense.
This content was researched and written with AI assistance. MEDVi referral links are affiliate links: we may earn a commission if you sign up. This is independent information, not medical advice or a clinical review.
The decision
Which should you choose, Hers or MEDVi?
Short answer: MEDVi scores higher on our published rubric, 5.7/10 against 5.3/10. Published pricing is not a like-for-like monthly comparison: Hers is $188 first month, then $298/mo; MEDVi is $179 first month, then $299/mo.
Consider Hers if
Women who want a female-focused platform and can budget at least $188 initially and $298/mo ongoing for a $149 medication path.
Consider MEDVi if
Users who want both oral and injectable compounded options in one telehealth program.
Scores follow our published methodology. Partnership status does not change the score or the factual comparison.
Hers
#26 of 37Best for women who want a female-focused platform and can budget at least $188 initially and $298/mo ongoing for a $149 medication path.
Visit Hers
MEDVi
#25 of 37Best for users who want both oral and injectable compounded options in one telehealth program.
Visit MEDVi(affiliate link)Side by side
Hers vs MEDVi at a glance
Compare the price unit as well as the number. A medication-only price, prepaid monthly equivalent and complete recurring program are not the same thing.
| Feature | Hers | MEDVi |
|---|---|---|
Why each oneHersA major women-focused telehealth platform with a direct Novo Nordisk partnership (Wegovy pill from $149 and pen from $199 before required membership) and a Lilly partnership (Zepbound medication from $299) alongside compounded options. MEDViA daily dissolvable GLP-1 tablet and a weekly compounded injection in one program, plus brand-name Wegovy and Zepbound on a $99 membership. | ||
| Our Score | 5.3/10 | 5.7/10 |
| Headline Price | $188 first month, then $298/mo | $179 first month, then $299/mo(affiliate link) |
| Medication Type | Both | Both |
| Insurance Accepted | No | No |
Best ForHersWomen who want a female-focused platform and can budget at least $188 initially and $298/mo ongoing for a $149 medication path MEDViUsers who want both oral and injectable compounded options in one telehealth program | ||
Watch out forHersPending federal enforcement against the parent company: on July 29, 2026 the FTC, joined by Utah and by California acting through Los Angeles County Counsel, sued Hims & Hers Health, Inc. in the Northern District of California over subscription billing, cancellation friction and sharing consumer health information with advertising platforms. The case status is Pending and these are allegations, not findings (checked 2026-09-03). MEDViFDA warning letter #721455, issued February 20, 2026, cites misleading labeling and marketing that implied MEDVi compounded the drugs and that compounded products were equivalent to or FDA-evaluated like approved brands. The letter does not allege unsafe medication | ||
| Ranking | #26 | #25 |
| Get started | Visit Hers | Visit MEDVi(affiliate link) |
Trade-offs
Strengths and cautions compared
Hers
Pros
- +Brand-name paths include Wegovy pill, Foundayo, and Ozempic pill medication from $149 and a Wegovy pen from $199. Wegovy and Foundayo carry FDA approval for weight management, Ozempic is approved for type 2 diabetes and is used off label here. With the required membership, a $149 medication path totals $188 initially and $298/mo ongoing
- +Zepbound access via the Lilly/Hims-Hers partnership announced 2026
- +Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
1 more documented strengths
- +Broader women's health platform, integrates weight loss with hormonal, skin, and wellness services
Cons
- −Pending federal enforcement against the parent company: on July 29, 2026 the FTC, joined by Utah and by California acting through Los Angeles County Counsel, sued Hims & Hers Health, Inc. in the Northern District of California over subscription billing, cancellation friction and sharing consumer health information with advertising platforms. The case status is Pending and these are allegations, not findings (checked 2026-09-03).
- −Every medication figure excludes the required Weight Loss Membership ($39 first month, then $149/mo); exact product and dose prices can increase the total above the $188/$298 floor
- −Support runs at big-platform scale, fine for routine refills, less personal if you want high-touch care
2 more documented cautions
- −Compounded pricing starts at $199/mo with stepped pricing at higher doses, budget for the dose you'll end up on, not the entry dose
- −Zepbound medication starts at $299 before the required membership; that path totals $338 in month one and at least $448/mo ongoing, with exact dose pricing potentially higher
MEDVi
Pros
- +One of the few compounded providers offering both oral tablets and injectable semaglutide
- +The landing page says the program is HSA and FSA eligible and includes dietician visits and care coaching, with a footnote making that subject to insurance and copay eligibility
- +Sleek onboarding experience with clear progress tracking through their patient portal
1 more documented strengths
- +$179 covers the first month of compounded semaglutide on MEDVi's landing page, including physician review, the personalized plan, medication and free shipping
Cons
- −FDA warning letter #721455, issued February 20, 2026, cites misleading labeling and marketing that implied MEDVi compounded the drugs and that compounded products were equivalent to or FDA-evaluated like approved brands. The letter does not allege unsafe medication
- −Its third-party records conflict: 4.3 out of 5 across 14,680 Trustpilot reviews with 12 percent of them at one star, against an F and no accreditation at the BBB
- −The $179 semaglutide price covers month one only; the FAQ on MEDVi's own landing page says refills are locked in at $299 a month, making the first year $3,468 rather than $2,148
2 more documented cautions
- −Brand-name Wegovy and Zepbound paths add a $99 membership plus a medication cost the page does not publish, and the same page's hero says "No membership or hidden fees!" directly above those cards; availability is subject to change
- −No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms
Our Verdict
MEDVi edges out Hers with a score of 5.7/10 vs 5.3/10. Published pricing is not a like-for-like monthly comparison: Hers is $188 first month, then $298/mo; MEDVi is $179 first month, then $299/mo.
Keep narrowing the decision
What should you compare next?
Use the unresolved part of this choice, not a generic related article. These guides own the broader medication, coverage or complete-cost question.
- Pill decisionCompare Wegovy pill prices and accessUse the dedicated guide for dose-specific costs, required memberships and which providers currently list the FDA-approved pill.Continue
- Treatment decisionCompare semaglutide providers and pricesMove from this head-to-head to the broader semaglutide market without confusing compounded products with FDA-approved brands.Continue
- Treatment decisionCompare tirzepatide providers and pricesReview provider options, price units and treatment context across the wider tirzepatide market.Continue
Cheapest complete recurring price in our index
Eden Health GLP-1
$99/mo month-to-month, from $34 on a plan · 6.9/10 · Both
Both Hers and MEDVi start above the cheapest complete recurring program we track. Across all 37 providers in our index, the lowest price with affirmative medication, consultation, and shipping inclusion is Eden Health GLP-1 at $99/mo, price checked August 28, 2026. It scores 6.9/10 and is not the highest-scored provider in our full rankings, so this is a cost floor rather than a recommendation. Worth knowing before you decide.
Reviews and pricing sources
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.
Still working out whether either one is above board? We check that separately: is Hers legit and is MEDVi legit, with the verification evidence behind each answer.
Our pick of these two: MEDVi · 5.7/10